Accumulated sum Rs 31,500 crore in 2015-16
The venture is applying to the Reserve Bank of India for approvals.
The Aditya Birla Group announced the merger of its two holding companies, Aditya Birla Nuvo and Grasim, to make the holding structure clearer, ensure stable cash flows and unlock value in its financial services arm
Vishal Kampani has big shoes to fill as his father is close to the Ambanis, the Wadias and the Ruias, says Dev Chatterjee.
A GST roll-out by April 1 looks difficult, giving the companies some succour.
Vishal Kampani said one of the important lessons he learnt from his father was to be humble.
Sixteen companies in the group registered a turnover of over $500 million, with ten of these registering a turnover of over $1 billion
The founders of Gland Pharma, led by Ravi Penmetsa, and KKR, together own 96 per cent of the company.
The private companies announced projects worth Rs 11.33 lakh crore (Rs 11.33 trillion) during 2014-16.
'The idea is to align the HR policies and work culture with changing times'.
Ahmedabad-based firm to fund deal through equal amount of equity and debt.
USL board said its second forensic audit by EY has revealed fund diversion worth Rs 1,225 cr to Mallya companies.
'It is surprising and unfortunate that unfounded allegations are now being made without any reference to me whatsoever,' Vijay Mallya said.
In 2007, Essar had said it would set up a $1.8-bn unit in Minnesota, but scaled down from a full-scale taconite steel mill project to pellet plant after the 2008 financial crisis
Firm makes disclosures of improper transactions worth Rs 1,225.3 crore with entities linked to beleaguered businessman
Unlike last year, investors turn cautious on e-commerce sector.
The company had received a loan restructuring package from banks under the 5/25 scheme last year.
Firms to find alternative export routes or face increased trade barriers
JLR, Tata Steel Europe CEOs caution staff on high risks of leaving the EU
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances